Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Very good read, thanks. Several candidate mecha

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154835
(Total Views: 612)
Posted On: 10/15/2021 11:30:41 PM
Posted By: ohm20
Very good read, thanks.

Quote:
Several candidate mechanisms for CRCI have been hypothesized based on clinical and preclinical studies. Increased systemic inflammation occurs in response to cancer, as well as to chemotherapy, radiotherapy, and surgery. Chronically elevated inflammation can lead to neuroinflammation that could result in neurotoxicity and increased oxidative damage. Evidence has also implicated mitochondrial dysfunction in neurons as well as disrupted neurogenesis and neuroplasticity.



Leronlimab fixes those.

Quote:
Genetic risk for CRCI is an ongoing area of study, with some evidence suggesting particular vulnerability among APOE*E4 carriers, the best-known genetic risk for Alzheimer disease.



Regular APOE regulates low-density lipoproteins and helps clear beta amyloid plaques in the brain. The APOE-E4 genetic variation is not as effective and allows an increase in low-density lipoproteins and plaques to accumulate. Inflammation decreases APOE production and TGF-b increases it. Leronlimab downregulates the inflammation and upregulates TGF-b which would increase the effectiveness of both APOE and the crippled APOE-E4.

Quote:
Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer
https://jamanetwork.com/journals/jama/fullarticle/2785382



(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us